Sep 9, 2026 07:29AM

Sep 9, 2026 04:26AM

Sep 8, 2026 08:10AM

Aug 6, 2026 07:00AM

Jun 13, 2026 07:30AM

Jun 13, 2026 07:30AM

Jun 1, 2026 07:30AM Intellia to present Phase 3 HAELO data at EAACI 2026 congress

Jun 1, 2026 07:30AM

May 11, 2026 07:30AM

Apr 27, 2026 02:50PM

Apr 27, 2026 10:10AM

Apr 27, 2026 07:03AM

Apr 27, 2026 07:00AM

Apr 27, 2026 07:00AM Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema

Apr 27, 2026 07:00AM

Apr 8, 2026 09:15AM

Mar 4, 2026 06:01AM

Mar 3, 2026 09:54AM

Mar 3, 2026 07:30AM

Mar 3, 2026 07:30AM

Mar 3, 2026 04:56AM Intellia Therapeutics (NTLA) PT Raised to $28 at Citizens After Very Positive FDA Action

Mar 2, 2026 03:25PM

Mar 2, 2026 02:48PM

Mar 2, 2026 02:18PM

Mar 2, 2026 02:04PM

Mar 2, 2026 12:28PM

Mar 2, 2026 12:05PM

Mar 2, 2026 10:25AM Intellia Therapeutics (NTLA) PT Raised to $19 at BofA Securities

Mar 2, 2026 07:30AM

Mar 2, 2026 07:30AM

Feb 26, 2026 01:28PM

Feb 26, 2026 07:30AM

Jan 27, 2026 11:29AM

Jan 27, 2026 08:00AM

Jan 27, 2026 08:00AM Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN

Dec 19, 2025 09:06AM

Nov 18, 2025 08:45AM

Nov 10, 2025 03:17PM

Nov 10, 2025 03:17PM

Nov 8, 2025 05:13PM

Nov 8, 2025 05:13PM

Nov 7, 2025 08:56AM Intellia Therapeutics (NTLA) PT Lowered to $9 at RBC Capital

Nov 6, 2025 04:00PM

Oct 31, 2025 09:54AM

Oct 31, 2025 07:27AM

Oct 30, 2025 04:55AM

Oct 29, 2025 04:24PM

Oct 28, 2025 06:26AM

Oct 27, 2025 07:31AM Intellia pauses gene therapy trials after liver safety event

Oct 27, 2025 07:30AM

331,677 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All